methyl carbapenems have high stability against hydrolysis by DHP-I due to the steric hindrance of the jS-methyl group at the C-l position.10'11} Therefore, since discovery of 1/3-methyl carbapenem, its derivatives have been mainly studied around the world for about fifteen years. Recently, several analogues such as BO-2727,12'13) S-4661,14) E-1010,15' 16) IH201 17) are at the clinical or preclinical stage. It is well known that carbapenems with a pyrrolidine moiety as a side chain have very potent antibacterial activity as it can been seen from the SAR studies for panipenem (1) and meropenem (2) . In a previous paper, we also reported on 1/3-methyl carbapenem derivatives with pyrrolidine moiety containing a quarternary ammonium. 18) In order to design a newparenteral carbapenemantibiotic that has potent activity against a wide spectrum of bacteria, our attention is focused on novel carbapenem derivatives with various cyclic amine moieties including pyrrolidine. We have synthesized a series of 1/J-methyl carbapenems with pyrrolidin-3-ylthio groups substituted with various cyclic amino carbonyl moieties at the C-5 position in the Corresponding author: kannoo@shina. sankyo. co.jp ylthio moiety show a potent antibacterial activity against a wide range of Gram-positive and Gram-negative bacteria, including methicillin-resistant Staphylococcus aureus (MRSA) and Pseudomonas aeruginosa and also moderate urinary recovery.
In this paper, we describe the synthesis and structureactivity relationships of the above mentioned 1/3-methyl carbapenem derivatives with cycloalkylamine moiety.
Chemistry
A series of carbapenem derivatives with cycloalkylamine moiety was synthesized by commonprocedures as shown in Scheme1. The side chains were synthesized from lhydroxyproline (3) as starting material. Proline derivatives 4 and 5, which were prepared by known methods19) from 3, were used to give thiol 6a~l and 7a~d via amidation with various amines (Figure 1 ) using lj '-carbonyldiimidazole (CDI) or mixed anhydride with pivaloyl chloride.
In particular, amines g, h, i and j were synthesized from 1420) as they were commercially unavailable (Scheme 2). Amine g was prepared by azidation, reductive degradation of the azide group and sequential protection with a 4-nitrobenzyloxycarbonyl (PNZ) group, and amine h was synthesized by animation with methylamine at a high temperature and pressure and sequential protection with PNZgroup. Amines i and j were also prepared from 14.
The cyanation of 14 followed by hydrogenation in the presence of PtO2 as a catalyst gave amine 20. Amine20
was protected with PNZgroup to give 23, and 24 was prepared via methylation of 21 with sodium hydride and methyl iodide since methylation of 23 under the same condition was unsuccessful.
Condensation of amines a~l and proline derivatives 4 or 5, and sequential deprotection of the 4-methoxybenzyl (PMB) group using trifluoromethanesulfonic acid (TfOH) and anisole, gave thiol 6a~l and 7a~d. Reagents and conditions: a) ref. 20; b) NaN3 / DMF; c) methylamine/MeOH; d) Ph3P /CH3CN then 1M NaOH, PNZC1 ; e) PNZC1, EtN(/-Pr)2, CH3CN; f) acetone cyanohydrin, DBU / CH3CN, reflux; g) PtO2, NH4OAc / EtOH; h) Z-Cl, EtN(/-Pr)2 / CH3CN; i) NaH, Mel, DMF; j) 7.5% Pd/C, H2 / EtOH; k) TFA /CH2C12 or HC1 / EtOAc 
Biological Properties
In vitro antibacterial activity and urinary recovery of novel carbapenems are shown in Table 1 and Table 2 . First, we investigated the ring size of aminocycloamines connected to 3-thiopyrrolidine moiety by an amide bond. As shown in Table 1 , all of the derivatives with azetidine, pyrrolidine and piperidine, showed potent antibacterial activity against a wide range of Gram-positive and Gramnegative bacteria. In general, N(H)-carbapenem derivatives (10a~d) exhibited greater antipseudomonal activity than N(Me)-carbapenem derivatives (lla~d) but the urinary recovery of 10a~d was obviously lower than that of lla~d. Although azetidine derivatives (10a and lla)
showed both potent antibacterial activity and exellent urinary recovery, their plasma half lives of 10a and lla were too short to evaluate them further as clinical candidates.
For the other derivatives, the antibacterial activity of four pyrrolidine derivatives (10b, 10c, lib and lie) was higher than that ofpiperidine derivatives (lOd and lid Furthermore, in order to explore carbapenems with better antipseudomonal activity, we focused on pyrrolidinylthio carbapenems containing a 3-substituted pyrrolidine moiety. The 3-substituted pyrrolidine moiety in 10b, which has the highest antipseudomonal activity, was modified by the addition of the one or more methyl or methylene groups.
The antibacterial activities of these carbapenems (10e1 01) are shown in 
Conclusion
We designed and synthesized novel 1/3-methyl carbapenem derivatives with cycloalkylamine moiety at the C-2 position and investigated their antibacterial activity and urinary recovery. We found (S)-3-(Nmethyl)ammomethylpyrrolidine derivative (lOh), which showed antibacterial activity against a wide range of Grampositive and Gram-negative bacteria, and moderate urinary VOL.54 NO. 12 re c overy.
General Methods
Experimental THE JOURNAL OF ANTIBIOTICS IR spectra were recorded on a Jasco FT-IR 8300 or Jasco FT-IR 8900 spectrometer. NMRspectra were determined on a JEOL or spectrometer using tetramethylsilane (TMS) or sodium 3-(trimethylsilyl)-propionate-(i4 (TSP) as the internal standard. Mass spectra were recorded on JEOLHX-100, SX-102A or AX-505H mass spectrometer. Optical rotations were measured with a Jasco DIP-370 polarimeter. Column chromatography was carried out on a Silica gel 60 (230-400mesh, Art. 9385, Merck) or a Cosmosil 75C18 PREP (75 /im, Nacalai Tesque, Inc.) column.
To a solution of4 (2.05g) in CH3CN(20ml) was added AyV'-carbonyldiimidazole (0.78 g) at room temperature and the resulting mixture was stirred at 40°C for 1 hour. To the solution, 3-aminoazetidine dihydrochloride (1.0g) and diisopropylethylamine (2.40ml) in MeOH (10ml) were added under ice cooling and the mixture was stirred at room temperature for 1 hour. The solvent was removed under reduced pressure, and the resulting residue was diluted with EtOAc. The organic layer was washed with aqueous NaHCO3 and brine, dried over MgSO4, and evaporated under reduced pressure. The crude oil was purified by silica gel column chromatography (EtOAc : MeOH=3 : 2) to give (2S,4S>2-(3-aminoazetidin- To the solution of (2S,4S)-2-(3-aminoazetidin-l- 
(12, 0.46 g) in CH3CN (4 ml) were added diisopropylethylamine (0. 14 ml) and a solution of 6a (0.43g) 
To the solution of4 (1.43g) in THF (10ml) were added dropwise Et3N (0.41 ml) and pivaloyl chloride (0.41 g) under ice cooling and the resulting mixture was stirred for 30 minutes. To this were added (S)-3-(4-nitrobenzyloxycarbonylamino)pyrrolidine trifluoroacetate (1.50g) and diisopropylethylamine (1.15 ml) in CH3CN(7 ml) under ice cooling and the mixture was stirred at room temperature for 2.5 hours. The solvent was removedunder reduced pressure, and the resulting residue was diluted with EtOAc. The organic layer was washed with water, aqueous NaHCO3 and brine, dried over MgSO4, and evaporated DEC. 2001 under reduced pressure. The crude oil was purified by silica gel column chromatography (EtOAc : CH2C12: CH3CN= 8.16-8.26 (4H, m).
.20 g) in CH3CN (6 ml) were added diisopropylethylamine (0.38 ml) and a solution of 6b (1.26g) in CH3CN(6ml) under ice cooling and the resulting mixture was stirred for 3 hours. The solvent was removed under reduced pressure, and the resulting residue was diluted with EtOAc. The organic layer was washed with water, aqueous NaHCO3and brine, dried over MgSO4, and evaporated under reduced pressure. The crude oil was purified by silica gel column chromatography (EtOAc :
MeOH=96:4) to give 8b (1.01 g) as a powder. IR (KBr) cm "1 3377, 1774, 1713, 1648, 1607, 1521, 1346, 852, 736; *H NMR (270MHz, DMSO-J6, TMS) 8 1. 10c-101 were prepared in a similar manner as that described for the preparation of 10b. However, lOd and lOg-101 were prepared as a free form without the addition of aqueous HC1during hydrogenation. ( 
To the solution of 5 (1.62g) in CH3CN (20ml) was added Af,7V'-carbonyldiimidazole (1.02g) at room temperature and the resulting mixture was stirred at 40°C for 1 hour. To this solution were added 3-aminoazetidine dihydrochloride (1.0 g) and diisopropylethylamine (2.40 ml) DEC. 2001 in MeOH (10ml) 
MS (FAB) rn/z: 515 (M+H)+.
To the solution of (25, 4S)-
ylcarbonyl]-pyrrolidine (0.73 g) in triftuoroacetic acid (7.25 ml) was added anisole (1.53ml) and trifluoromethanesulfonic acid (0.25 ml) under ice cooling and the mixture was stirred at room temperature for 1.5 hours. The solvent was removed under reduced pressure, and the residue was washedwith hexane to remove the anisole and dissolved in 
(12, 0.70 g) in CH3CN (10 ml) were added diisopropylethylamine (0. 1 8 ml) and a solution of 7a (0.43 g) in CH3CN(10ml) under ice cooling and the resulting mixture was stirred for 2 days. The solvent was removedunder reduced pressure, and the resulting residue was diluted with EtOAc. The organic layer was washed with water, aqueous NaHCO3and brine, dried over MgSO4, and evaporated under reduced pressure. The crude oil was purified by silica gel column chromatography (EtOAc : 
The solution of 9a (0.25g) in THF (3ml) and water (2 ml) was hydrogenated under H2 atmosphere in the presence of 10% Pd/C (0.25g) at 30°C for 1.5 hours. The catalyst was filtered away, and the filtrate was washed with Et2O. The aqueous layer was evaporated under reduced pressure, and the concentrated solution (2 ml 3.15-3.27 (1H, m), 3.27-3.40 (1H, m), 3.46-3.49 (1H, m), 3.50-4.35 (10H, m), 4.45-4.65 (1H, m). MS (FAB) m/z: 439 (M+H)+. 
Measurement of Antibacterial Activity
Bacteria of 107 cfu/ml were inoculated on nutrient agar (Eiken Chemical Co., Ltd.) and the MIC was measured by the two-fold serial dilution method.
